By acting on key areas of the brain that regulate appetite and satiety, GLP-1 therapies help reduce hunger, curb cravings, and promote a sustained feeling of fullness
For some people, higher protein mildly raises blood ketone levels rather than reducing them
Practical management strategies can significantly improve tolerability
Keywords: GLP-1, psoriasis, hidradenitis suppurativa, liraglutide, semiglutide Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are highly effective pharmacologic agents for managing type 2 diabetes (T2D) and obesity
19,20 In the gastrointestinal tract, GLP-1RAs can activate the autonomic nervous system that regulates gastrointestinal motility to slow the movement of food from the stomach to the intestines, a process called gastric emptying